Garcia-Heras J, Martin J A, Day D W, Scacheri P, Witchel S F
Texas Department of Health, Bureau of Laboratories, Genetic Testing Center, Denton 76202-2467, USA.
Am J Med Genet. 1997 Jun 27;70(4):404-8. doi: 10.1002/(sici)1096-8628(19970627)70:4<404::aid-ajmg13>3.0.co;2-l.
We report a de novo dup(X)(q23-->q26) in a 3-year-old girl with growth retardation, developmental delay, and minor anomalies. X-inactivation in lymphocytes by BRDU labeling showed the abnormal X was late replicating. The androgen receptor assay (HAR) demonstrated a skewed methylation (88.8%) of the paternal allele and a 11.2% methylation of the maternal allele. These data, which suggest the duplication was paternally inherited, are the first parental-origin identification of a duplication Xq. The mild phenotype of the patient may be related to the size and region of the duplication, the low percentage of a dup(X) active detected by the HAR assay, or a combination of these mechanisms.
我们报告了一名3岁女童,其患有生长发育迟缓、发育延迟及轻微异常,存在新发dup(X)(q23→q26)。通过溴脱氧尿苷(BRDU)标记检测淋巴细胞中的X染色体失活情况,显示异常的X染色体复制较晚。雄激素受体检测(HAR)表明父本等位基因甲基化偏斜(88.8%),母本等位基因甲基化率为11.2%。这些数据表明该重复是父系遗传的,这是首次对Xq重复进行亲代来源鉴定。患者的轻度表型可能与重复的大小和区域、HAR检测中检测到的dup(X)活性低百分比,或这些机制的组合有关。